| 000 | 01727 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513050047.0 | ||
| 264 | 0 | _c19950324 | |
| 008 | 199503s 0 0 eng d | ||
| 022 | _a0009-7322 | ||
| 024 | 7 |
_a10.1161/01.cir.91.5.1427 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKonstantopoulos, K | |
| 245 | 0 | 0 |
_aShear-induced platelet aggregation is inhibited by in vivo infusion of an anti-glycoprotein IIb/IIIa antibody fragment, c7E3 Fab, in patients undergoing coronary angioplasty. _h[electronic resource] |
| 260 |
_bCirculation _cMar 1995 |
||
| 300 |
_a1427-31 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAbciximab |
| 650 | 0 | 4 | _aAngioplasty, Balloon, Coronary |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 |
_aAspirin _xtherapeutic use |
| 650 | 0 | 4 |
_aCoronary Disease _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 | _aHemorheology |
| 650 | 0 | 4 |
_aHeparin _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin Fab Fragments _xadministration & dosage |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadministration & dosage |
| 700 | 1 | _aKamat, S G | |
| 700 | 1 | _aSchafer, A I | |
| 700 | 1 | _aBañez, E I | |
| 700 | 1 | _aJordan, R | |
| 700 | 1 | _aKleiman, N S | |
| 700 | 1 | _aHellums, J D | |
| 773 | 0 |
_tCirculation _gvol. 91 _gno. 5 _gp. 1427-31 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/01.cir.91.5.1427 _zAvailable from publisher's website |
| 999 |
_c7866519 _d7866519 |
||